Merck & Co., Inc. 13D and 13G filings for Yumanity Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-04 2:28 pm Purchase | 2020-12-22 | 13G | Yumanity Therapeutics, Inc. YMTX | Merck & Co. Inc. MRK | 75,286 5.200% | 75,286 (New Position) | Filing |